Identification of resistance mechanisms to EGFR treatment in the real world using a clinicogenomic database Published April 2018 Citation Singal, G, Li, G, Agarwala, V, Kaushik, G, O’Connell, C, Alpha-CobbG, Caron, T, Bourque, D, Guria, A, Frank, S, Frampton, G, Carson, K, Abernethy, A.P., Miller, V.A. . AACR Annual Meeting. . https://4076230.fs1.hubspotusercontent-na1.net/hubfs/4076230/flatiron-com-pdf/AACR-2018-FH-FMI-CGDB-Poster-180411.pdf Authors: Sources:American Association for Cancer Research Annual Meeting Share Posted inPublicationsDrug discovery More publicationsISPOR EuropeOctober 2025Incidence of neutropenia adverse events identified in electronic health care records among initiators of CDK4/6 inhibitors with advanced breast cancer in the UKTaylor L, Horne E, Samani A, et al.Publication summaryPublicationsBreast cancerISPOR EuropeOctober 2025Assessing bias in LLM-extracted real-world data: A health equity analysis of access to care and outcomes in metastatic breast cancerMbah O, Ho G, Keane C, Yuan Q, Ryals C.Publication summaryPublicationsMetastatic breast cancerISPOR EuropeOctober 2025Real-world insights into prostate cancer management using EHR-derived data from the UKHorne E, Samani A, Sujenthiran A, et al. Publication summaryPublicationsProstate cancer